Institut Pasteur de Dakar

Institut Pasteur de Dakar has sequenced the first 40 human whole genomes in Senegal using Illumina and Oxford Nanopore Technologies. The institution launched a clinical laboratory and bioinformatics platform for testing early-onset breast cancer predisposition and rare heritable gene changes. A multidisciplinary research program integrating genomics, infectious diseases, and environmental factors aims to address cancer's growing burden in Senegal and Africa.